A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome

DiNardo, C. D., Hochhaus, A., Frattini, M. G., Yee, K., Zander, T., Krämer, A., Chen, X., Ji, Y., Parikh, N. S., Choi, J., & Wei, A. H. (2022). A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome. Journal of Cancer Research and Clinical Oncology, 149(3), 1145–1158. https://doi.org/10.1007/s00432-022-03983-6

Authors:

Courtney D DiNardo

Andreas Hochhaus

Mark G Frattini

Karen Yee

Thomas Zander

Alwin Krämer

Xueying Chen

Yan Ji

Nehal S Parikh

Joanne Choi

Andrew H Wei